Overall efficacy and safety of olanzapine 5 mg added to triplet antiemetics for an anthracycline-containing regimen in patients with breast cancer: a phase 3, double-blind, randomised, placebo-controlled trial

Mitsue Saito, Hirotoshi Iihara, Mototsugu Shimokawa, Ryoko Udagawa, Michiko Tsuneizumi, Manabu Futamura, Yuko Ishikawa, Hideaki Ogata, Hiroko Bando, Hiroaki Shima,

The Lancet Oncology · 2025 · 12 citations · 20 references

Concepts

References

20